Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma
-
By
-
Jakub Halámek
-
Ivan Špička
-
Zdeněk Krška
-
Kristian Chrz
-
May 20, 2026
-
Clinical Scorecard: Clinical Case Study: Evaluating Cytoreductive Surgery in the Management of Extramedullary Plasmacytoma
At a Glance
| Category | Detail |
|---|
| Condition | Extramedullary Plasmacytoma (EMP) |
| Key Mechanisms | Pathological monoclonal proliferation of plasma cells, typically occurring outside the bone marrow. |
| Target Population | Patients with advanced extramedullary plasmacytoma, particularly those with exhausted systemic therapy options. |
| Care Setting | Surgical intervention in a hospital setting, specifically within a department of surgery. |
Key Highlights
- Extramedullary plasmacytoma is a rare manifestation of multiple myeloma, occurring in 0.5%-5.2% of cases at diagnosis.
- Partial cytoreductive surgery can be considered in advanced cases after conventional treatments have failed.
- The surgical procedure was performed without periprocedural complications, leading to complete healing of the surgical wound.
Guideline-Based Recommendations
Diagnosis
- Utilize multimodal diagnostics including imaging (CT, MRI, PET/CT) and laboratory tests (plasma protein electrophoresis, blood count).
Management
- Primary treatment involves biological therapy, chemotherapy, and may include surgical intervention in select cases.
Monitoring & Follow-up
- Regular follow-up with imaging and laboratory tests to assess disease progression and response to therapy.
Risks
- Potential for disease progression despite surgical intervention; careful consideration of surgical indications is necessary.
Patient & Prescribing Data
67-year-old male with advanced extramedullary plasmacytoma.
Surgical cytoreduction may be a safe and reproducible option in specific cases after conventional therapies are exhausted.
Clinical Best Practices
- Interdisciplinary cooperation between haematologists and surgeons is essential for optimal patient management.
- Consider surgical options in advanced EMP cases where systemic therapies have failed.
Related Resources & Content
